Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/132868
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Gebhart, Geraldine |
dc.contributor.author | Gámez, Cristina |
dc.contributor.author | Holmes, Eileen |
dc.contributor.author | Robles, Javier |
dc.contributor.author | Garcia, Camilo |
dc.contributor.author | Cortés Romera, Montserrat |
dc.contributor.author | De Azambuja, Evandro |
dc.contributor.author | Fauria, Karine |
dc.contributor.author | Van Dooren, Veerle |
dc.contributor.author | Aktan, Gursel |
dc.contributor.author | Coccia-Portugal, Maria Antonia |
dc.contributor.author | Kim, Sung-Bae |
dc.contributor.author | Vuylsteke, Peter |
dc.contributor.author | Cure, Hervé |
dc.contributor.author | Eidtmann, Holger |
dc.contributor.author | Baselga Torres, Josep, 1959- |
dc.contributor.author | Piccart, Martine |
dc.contributor.author | Flamen, Patrick |
dc.contributor.author | Di Cosimo, Serena |
dc.date | 2019-05-08T16:01:53Z |
dc.date | 2019-05-08T16:01:53Z |
dc.date | 2013-11 |
dc.date | 2019-05-08T16:01:53Z |
dc.identifier.citation | 0161-5505 |
dc.identifier.citation | 689355 |
dc.identifier.uri | http://hdl.handle.net/2445/132868 |
dc.format | 7 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | The Society of Nuclear Medicine and Molecular Imaging |
dc.relation | Reproducció del document publicat a: https://doi.org/10.2967/jnumed.112.119271 |
dc.relation | Journal of Nuclear Medicine, 2013, vol. 54, num. 11, p. 1862-1868 |
dc.relation | https://doi.org/10.2967/jnumed.112.119271 |
dc.rights | (c) The Society of Nuclear Medicine and Molecular Imaging, 2013 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Càncer de mama |
dc.subject | Diagnòstic |
dc.subject | Tomografia per emissió de positrons |
dc.subject | Raigs X |
dc.subject | Breast cancer |
dc.subject | Diagnosis |
dc.subject | Positron emission tomography |
dc.subject | X-rays |
dc.title | 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |